Organisation paid for research Program year 2025 Source: CMS Open Payments

Ascada Health, PC

Neither a doctor nor a teaching hospital

Research payments

$813,852

21 payments

Through program year 2025, Ascada Health, PC is reported as receiving $813,852 in research payments, across 21 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $136,806 4
2024 Research $671,089 16
2023 Research $5,958 1

Breakdown

Who paid Research payments · program years 2023–2025
  1. Ortho-Clinical Diagnostics, Inc. $537,813 13 payments
  2. AstraZeneca Pharmaceuticals LP $270,082 7 payments
  3. AstraZeneca UK Limited $5,958 1 payment
Studies the money was for Research payments · program years 2023–2025
  1. Lyra Direct SARS-CoV-2 and Lyra SARS-CoV-2 Validation Study $537,813 13 payments
  2. a phase 3,randomised,double blind,active controlled study to assess the efficacy,safety and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease ckd progression in participants with ckd and high blood pressure $179,617 4 payments
  3. A Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week, 3-Way, Partial-replicate Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide and Albuterol (BDA) Delivered by MDI HFO Compared with BDA Delivered by MDI HFA in Participants with Asthma $64,258 2 payments
  4. a phase III,randomised,double blind,placebo controlled,event driven study to assess the efficacy,safety and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure $26,207 1 payment
  5. A Phase 2, Randomised, Double-Blind, Placebo and Active Comparator-Controlled Study to Assess Efficacy and Safety of Multiple Dose Levels of AZD5718 Given Orally Once Daily for Twelve Weeks in Adults with Moderate-to-Severe Uncontrolled Asthma $5,958 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record